BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 2417744)

  • 21. A new milrinone analog: role of binding to A1 adenosine receptor in its positive inotropic effect on isolated guinea pig and rat atria.
    Floreani M; Borea PA; Gessi S; Mosti L; Fossa P; Dorigo P
    J Pharmacol Exp Ther; 1997 Nov; 283(2):541-7. PubMed ID: 9353368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does the positive inotropic action of a novel cardiotonic agent, MCI-154, involve mechanisms other than cyclic AMP?
    Kitada Y; Narimatsu A; Suzuki R; Endoh M; Taira N
    J Pharmacol Exp Ther; 1987 Nov; 243(2):639-45. PubMed ID: 2824754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical mechanisms for the inotropic effect of the cardiotonic drug milrinone.
    Earl CQ; Linden J; Weglicki WB
    J Cardiovasc Pharmacol; 1986; 8(4):864-72. PubMed ID: 2427830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A report on the positive inotropic action of amrinone.
    Cargnelli G; Padrini R; Piovan D; Piacenza G; Ferrari M; Gallucci V
    Boll Soc Ital Biol Sper; 1982 Jul; 58(13):793-9. PubMed ID: 7126350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of milrinone on ethanol and halothane induced cardiodepression.
    Neira S; Penna M
    Acta Physiol Pharmacol Latinoam; 1988; 38(2):193-211. PubMed ID: 2847492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is milrinone equivalent to amrinone during enflurane anesthesia in the dog?
    Makela VH; Kapur PA
    Anesth Analg; 1988 Apr; 67(4):349-55. PubMed ID: 3354869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of amrinone on contraction and K+-induced contracture of normal and subacutely failed cat ventricular muscle.
    Gaide MS; Kimura S; Lodge NJ; Cameron JS; Kozlovskis PL; Myerburg RJ; Bassett AL
    Circulation; 1986 Mar; 73(3 Pt 2):III36-45. PubMed ID: 3943180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the mechanism of action of the bipyridine milrinone on the heart.
    Farah AE; Frangakis CJ
    Basic Res Cardiol; 1989; 84 Suppl 1():85-103. PubMed ID: 2554875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of milrinone on left ventricular performance and myocardial contractility in patients with severe heart failure.
    Sonnenblick EH; Grose R; Strain J; Zelcer AA; LeJemtel TH
    Circulation; 1986 Mar; 73(3 Pt 2):III162-7. PubMed ID: 3510772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial actions of milrinone: characterization of its mechanism of action.
    Rapundalo ST; Grupp I; Grupp G; Abdul Matlib M; Solaro RJ; Schwartz A
    Circulation; 1986 Mar; 73(3 Pt 2):III134-44. PubMed ID: 2417746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-related cardiovascular effects of amrinone during enflurane anesthesia in the dog.
    Makela VH; Kapur PA
    Anesth Analg; 1986 Aug; 65(8):849-52. PubMed ID: 3729021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential inhibition of cardiac cyclic nucleotide phosphodiesterase isozymes by cardiotonic drugs.
    Harrison SA; Chang ML; Beavo JA
    Circulation; 1986 Mar; 73(3 Pt 2):III109-16. PubMed ID: 3002661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective inhibition of cAMP phosphodiesterase III activity by the cardiotonic agent saterinone in guinea pig myocardium.
    Brunkhorst D; von der Leyen H; Meyer W; Schmidt-Schumacher C; Scholz H
    Arzneimittelforschung; 1988 Sep; 38(9):1293-8. PubMed ID: 2852013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pharmacological investigation of the contribution of muscarinic receptor-linked potassium channels to the reversal by carbachol of positive inotropic responses of rabbit left atrium to cyclic AMP-generating agents.
    Ray A; MacLeod KM
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1594-601. PubMed ID: 7690405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of amrinone on sodium-calcium exchange in cardiac sarcolemmal vesicles.
    Mallov S
    Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):197-210. PubMed ID: 6635316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive inotropic activity of 5-amino-6-cyano-1,3-dimethyl-1,2,3,4-tetrahydropyrido[2,3-d]pyrim idine-2,4-dione in cardiac muscle from guinea-pig and man. Part 6: Compounds with positive inotropic activity.
    Heber D; Heers C; Ravens U
    Pharmazie; 1993 Jul; 48(7):537-41. PubMed ID: 7692456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-activity relationships of milrinone analogues determined in vitro in a rabbit heart membrane Ca(2+)-ATPase model.
    Cody V; Wojtczak A; Davis FB; Davis PJ; Blas SD
    J Med Chem; 1995 May; 38(11):1990-7. PubMed ID: 7783130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of acidosis on cardiotonic effects of milrinone.
    Tanaka M; Ishikawa T; Nishikawa T; Goto K; Sato S
    Anesthesiology; 1998 Mar; 88(3):725-34. PubMed ID: 9523817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of amrinone and related drugs on intracellular calcium in isolated mammalian cardiac and vascular smooth muscle.
    Morgan JP; Gwathmey JK; DeFeo TT; Morgan KG
    Circulation; 1986 Mar; 73(3 Pt 2):III65-77. PubMed ID: 3943182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.